BlackRock, Inc. 13D and 13G filings for Astria Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS | BlackRock Inc. BLK | 3,499,478 6.200% | 0 (Unchanged) | Filing |
| 2024-10-24 2:02 pm Purchase | 2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS | BlackRock Inc. BLK | 3,499,478 6.200% | 1,043,825 (+42.51%) | Filing |
| 2024-03-07 12:29 pm Purchase | 2024-02-29 | 13G | Astria Therapeutics, Inc. ATXS | BlackRock Inc. BLK | 2,455,653 4.500% | 271,095 (+12.41%) | Filing |
| 2024-01-29 5:26 pm Purchase | 2023-12-31 | 13G | Astria Therapeutics, Inc. ATXS | BlackRock Inc. BLK | 2,184,558 6.000% | 2,131,485 (+4016.14%) | Filing |
| 2022-02-24 5:23 pm Purchase | 2021-12-31 | 13G | Astria Therapeutics, Inc. ATXS | BlackRock Inc. BLK | 53,073 0.400% | 53,073 (New Position) | Filing |